Results 41 to 50 of about 734,803 (234)

Human papillomavirus vaccines: WHO position paper, October 2014-Recommendations.

Vaccine, 2015
This article presents the World Health Organization's (WHO) recommendations for the use of vaccines against diseases caused by human papillomaviruses (HPV) from the WHO position paper on Human papillomavirus vaccines: WHO position paper - October 2014 ...
Releve Epidemiologique Hebdomadaire
semanticscholar   +1 more source

Human Papillomavirus Vaccination – A Moment of Prevention, a Lifetime of Protection

Indian Journal of Public Health
Human papillomavirus (HPV) vaccination is the primary preventive strategy to reduce the burden of cervical cancer as well as other HPV-related malignancies.
Priya Abraham
doaj   +1 more source

Cost‐effectiveness analysis of human papillomavirus (HPV) genotyping strategies for management of HPV‐positive women in cervical cancer screening

International Journal of Cancer, EarlyView.
What's New? Persistent infection with high‐risk human papillomavirus (HPV) causes most invasive cervical cancer cases, leading many countries to transition from cytology to primary HPV‐based screening. Despite the benefits, HPV‐based screening may also lead to unnecessary procedures, psychological burden, and strain on healthcare systems.
Kelsi R. Kroon, Johannes A. Bogaards, Johannes Berkhof   +2 more
wiley   +1 more source

Human papillomavirus vaccine: An update on recent developments and review of real world data on efficacy

Current Medicine Research and Practice, 2023
Cervical cancer is the fourth most common cancer in women worldwide and is a significant public health problem. Currently, there are three bivalent human papillomavirus (HPV) vaccines targeting high-risk HPV types (16, 18), two quadrivalent vaccines ...
Shalini Rajaram, Ipshita Sahoo, Ayush Heda, Lakhwinder Singh   +3 more
doaj   +1 more source

Nonavalent HPV vaccine to prevent recurrent anal or vulvar high‐grade squamous intraepithelial lesions (VIVA trial): A randomized, double‐blind, placebo‐controlled trial

International Journal of Cancer, EarlyView.
What's New? Anal and vulvar high‐grade squamous intraepithelial lesions (HSILs) frequently recur following treatment. Additional genital and anal procedures, however, can be distressing for patients and are potentially disfiguring. This trial assessed whether the 9‐valent human papillomavirus (9vHPV) vaccine reduces HSIL recurrence risk or HPV ...
Helen C. Stankiewicz Karita, Amalia S. Magaret, David R. Doody, Jeffrey T. Schouten, Constance Mao, Warner K. Huh, Verena S. Grieco, Matthew A. Seymour, Dana Varon, Kelly H. Shrader, Long Fu Xi, Denise A. Galloway, Anna Wald, Margaret M. Madeleine   +13 more
wiley   +1 more source

Associations Between Exposure to and Expression of Negative Opinions About Human Papillomavirus Vaccines on Social Media: An Observational Study

Journal of Medical Internet Research, 2015
Background Groups and individuals that seek to negatively influence public opinion about the safety and value of vaccination are active in online and social media and may influence decision making within some communities.
A. Dunn, J. Leask, Xujuan Zhou, K. Mandl, E. Coiera   +4 more
semanticscholar   +1 more source

The Use of Both Therapeutic and Prophylactic Vaccines in the Therapy of Papillomavirus Disease

Frontiers in Immunology, 2020
Human papillomavirus (HPV) is the most common sexually transmitted virus. The high-risk HPV types (i.e., HPV16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59) are considered to be the main etiological agents of genital tract cancers, such as cervical ...
A. Garbuglia, D. Lapa, C. Sias, M. Capobianchi, P. Del Porto   +4 more
semanticscholar   +1 more source

Parental Justifications for Not Vaccinating Children or Adolescents against Human Papillomavirus (HPV)

Vaccines, 2023
Vaccination coverage against Human Papillomavirus (HPV) is low compared with uptake of other vaccines in many countries, including Brazil. The aim of this study was to examine the main reasons provided by parents or guardians of a target population that ...
Eliza S. Rodrigues, Elisa D. T. Mendes, Luciana B. Nucci   +2 more
doaj   +1 more source

Increased cervical cancer incidence in the target age of screening—Variation by mode of detection

International Journal of Cancer, EarlyView.
What's New? Cervical cancer rates have risen in several high‐income countries despite advances in screening. Here, using data on cervical cancer diagnoses between 1996 and 2022 in Finland, the authors examined incidence trends according to detection mode—screening, between screenings, or outside screening programs—with attention to the role of human ...
Jenna Snellman, Maiju Pankakoski, Sirpa Heinävaara, Veli‐Matti Partanen, Maija Vahteristo   +4 more
wiley   +1 more source

Safety of human papillomavirus vaccines: a review

Expert Opinion on Drug Safety, 2015
Introduction: Between 2006 and 2009, two different human papillomavirus virus (HPV) vaccines were licensed for use: a quadrivalent (qHPVv) and a bivalent (bHPVv) vaccine. Since 2008, HPV vaccination programmes have been implemented in the majority of the
M. Stillo, P. Carrillo Santisteve, P. Lopalco   +2 more
semanticscholar   +1 more source